Hall Laurie J Trustee Infinity Pharmaceuticals, Inc. Transaction History

Hall Laurie J Trustee

  • $316 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Oct 02, 2017
SELL
$0.94 - $1.35 $441 - $634
-470 Closed
0 $0
Q2 2017

Aug 22, 2017
BUY
N/A
470
470 $0

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Hall Laurie J Trustee Portfolio

Follow Hall Laurie J Trustee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email